Pharmaceuticals · Pharmaceuticals: Major · NSE: ZENITHDRUG · data 2026-10-30

Zenith Drugs Ltd.

₹37-0.80% on 30 OctHealth: Average 4.8/10

Feb 2026Low ₹35.2 · High ₹53.9-26.0%

In plain words

Price: 42.3% below its 52-week high of ₹64.1.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹37

Market cap

₹64 cr

P/E

16.1

P/B

0.9

ROE

5.5%

ROCE

9.3%

Debt / equity

0.75

Dividend yield

0.00%

1-year return

-40.5%

52-week high

₹64.1

52-week low

₹33.3

Operating margin

3.6%

Growth

Revenue (last 12 months)	₹171 cr
Net profit (last 12 months)	₹4 cr
Sales growth, 3 years (yearly)	14.3%
Profit growth, 3 years (yearly)	-8.5%

Smart-money activity

5/100 · Weak over the last ~60 sessions

Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

● Deal

16 Sept 26Deal Bulk deal: BINDU GARG bought ₹0.79 cr (net ₹0 cr) -5.7% next session

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Zenith Drugs Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.75.

What is Zenith Drugs Ltd.'s P/E ratio?

About 16.1, based on the last 12 months' earnings and a price of ₹37 (data 2026-10-30).

What is the 52-week high and low of Zenith Drugs Ltd.?

The 52-week high is ₹64.1 and the 52-week low is ₹33.3.

Similar companies

Sunil Healthcare Ltd. (SUNLOC) · Vilin Bio Med Ltd. (VILINBIO) · Onyx Biotec Ltd. (ONYX) · Vivimed Labs Limited (VIVIMEDLAB) · Mangalam Drugs & Organics Ltd. (MANGALAM)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ZENITHDRUG in NSE Scanner →